Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 318.50
Bid: 318.00
Ask: 321.50
Change: 9.50 (3.07%)
Spread: 3.50 (1.101%)
Open: 313.50
High: 323.00
Low: 311.00
Prev. Close: 309.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: HSBC likes Haleon, cuts Flutter to 'hold'

Thu, 18th Apr 2024 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

Bernstein raises Diageo price target to 3,600 (3,440) pence - 'outperform'

----------

HSBC starts Haleon with 'buy' - price target 370 pence

----------

HSBC cuts Flutter Entertainment to 'hold' (buy) - price target 15,900 (17,000) pence

----------

UBS raises Entain price target to 840 (830) pence - 'neutral'

----------

Jefferies raises Standard Chartered price target to 1,300 (1,050) pence - 'buy'

----------

JPMorgan raises Antofagasta price target to 1,700 (1,320) pence - 'underweight'

----------

JPMorgan cuts Rio Tinto price target to 6,610 (6,630) pence - 'overweight'

----------

FTSE 250

----------

Deutsche Bank raises International Distributions Services to 'hold' (sell)

----------

UBS cuts Eurowag price target to 135 (145) pence - 'buy'

----------

Berenberg raises Spire Healthcare price target to 300 (286) pence - 'buy'

----------

RBC raises Spire Healthcare price target to 310 (290) pence - 'outperform'

----------

UBS cuts SSP to 'neutral' (buy) - price target 225 (320) pence

----------

Jefferies cuts Harbour Energy price target to 350 (360) pence - 'buy'

----------

SMALL CAP, AIM AND OTHER MAIN MARKET

----------

Stifel raises Oxford BioMedica to 'buy' (hold) - price target 300 (280) pence

----------

Barclays cuts Just Eat Takeaway price target to 1,470 (1,480) pence - 'equal weight'

----------

RBC raises Ashtead Technology price target to 780 (695) pence - 'outperform'

----------

By Eric Cunha, Alliance News news editor

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
14 May 2020 09:19

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

UK BROKER RATINGS SUMMARY: Berenberg Raises HSBC To Hold From Sell

Read more
6 May 2020 15:07

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

Oxford Biomedica Sinks To Loss In 2019 But Remains Optimistic

Read more
6 May 2020 12:52

Oxford Biomedica swings to loss as licensing revenue falls

(Sharecast News) - Gene and cell therapy company Oxford Biomedica reported an improvement in bioprocessing and commercial development revenues to ?47.3m in its preliminary results on Wednesday, from ?40.5m.

Read more
29 Apr 2020 16:13

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
28 Apr 2020 11:13

Liberum hikes target price on Oxford Biomedica

(Sharecast News) - Analysts at Liberum hiked their target price on gene and cell therapy company Oxford BioMedica from £8.60 per share to £10.90 on Tuesday, citing demand at its new OxBox manufacturing facility.

Read more
8 Apr 2020 16:13

Oxford Biomedica joins Covid-19 vaccine consortium

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has joined a consortium led by the Jenner Institute at Oxford University, it announced on Wednesday, to rapidly develop, scale-up and manufacture a potential vaccine candidate for Covid-19, called 'ChAdOx1 nCov-19'.

Read more
8 Apr 2020 14:46

UK TRADING UPDATE SUMMARY: Novacyt Gets WHO Covid-19 Test Kit Okay

UK TRADING UPDATE SUMMARY: Novacyt Gets WHO Covid-19 Test Kit Okay

Read more
20 Mar 2020 15:57

DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares

DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares

Read more
19 Mar 2020 10:59

Oxford Biomedica Expects 2019 Loss As Chair Steps Down, Signs New Deal

Oxford Biomedica Expects 2019 Loss As Chair Steps Down, Signs New Deal

Read more
4 Feb 2020 12:10

Oxford Biomedica Sells USD8.4 Million In Orchard Therapeutics Shares

Oxford Biomedica Sells USD8.4 Million In Orchard Therapeutics Shares

Read more
19 Dec 2019 16:27

Oxford Biomedica Extends Agreement With Novartis By Five Years

Oxford Biomedica Extends Agreement With Novartis By Five Years

Read more
30 Sep 2019 09:55

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

BROKER RATINGS SUMMARY: Barclays Cuts Whitbread And Raises SSE

Read more
28 May 2019 13:18

Novo Holdings pours ?53.5m into Oxford Biomedica

(Sharecast News) - Gene and cell therapy company Oxford Biomedica announced on Tuesday that Novo Holdings has agreed to invest up to £53.5m in the group, in return for new ordinary shares representing up to 10.1% of the outstanding shares after the capital increase.

Read more
15 Mar 2019 12:46

Friday broker round-up

(Sharecast News) - Bakkavor Group: Berenberg downgrades to sell with a target price of 105p.

Read more
14 Mar 2019 14:16

Oxford Biomedica swings to positive earnings in 2018

(Sharecast News) - Gene and cell therapy group Oxford Biomedica reported a 72% increase in gross income in its preliminary results for the year ended 31 December on Thursday, to £67.9m.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.